Lucrecia Yáñez Selected Research

Biomarkers (Surrogate Marker)

12/2017

Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucrecia Yáñez Research Topics

Disease

7	Neoplasms (Cancer) 03/2024 - 04/2015
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2019 - 10/2017
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2023 - 01/2021
4	Infections 01/2023 - 12/2021
2	Sepsis (Septicemia) 03/2024 - 01/2022
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 04/2019
2	Pneumonia (Pneumonitis) 09/2022 - 03/2022
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 04/2019
2	Thrombocytopenia (Thrombopenia) 06/2019 - 01/2019
1	Septic Shock (Toxic Shock Syndrome) 03/2024
1	Cross Infection (Nosocomial Infection) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Bacteremia 01/2023
1	Diarrhea 01/2023
1	Mucositis 09/2022
1	Febrile Neutropenia 01/2022
1	Fusariosis 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Rheumatoid Arthritis 01/2021
1	Neutropenia 01/2021
1	Disease Progression 06/2019
1	Lymphopenia (Lymphocytopenia) 06/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2019
1	Chromosomal Instability (Chromosome Stability) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Fanconi Anemia (Fanconi's Anemia) 01/2019
1	Second Primary Neoplasms (Neoplasms, Second) 10/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017
1	Carcinogenesis 04/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 09/2005
1	Protein S Deficiency (Deficiency, Protein S) 09/2005

Drug/Important Bio-Agent (IBA)

4	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 03/2022
4	Rituximab (Mabthera)FDA Link 01/2021 - 10/2017
2	UbiquitinIBA 12/2021 - 01/2021
1	Carbapenems (Carbapenem Antibiotics)IBA 03/2024
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Cefepime (Maxipime)FDA LinkGeneric 01/2022
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2022
1	Meropenem (Merrem)FDA LinkGeneric 01/2022
1	LactamsIBA 01/2022
1	ibrutinibIBA 12/2021
1	tisagenlecleucelIBA 04/2019
1	axicabtagene ciloleucelIBA 04/2019
1	tetrachloroisophthalonitrile (Bravo)IBA 01/2019
1	Thrombopoietin ReceptorsIBA 01/2019
1	Fanconi Anemia Complementation Group ProteinsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	Dihydrotachysterol (AT 10)IBA 10/2017
1	Cytostatic AgentsIBA 01/2017
1	fludarabineIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 04/2015
1	DNA (Deoxyribonucleic Acid)IBA 04/2015
1	thymoglobulin FDA Link 09/2014
1	Factor XII (Hageman Factor)IBA 09/2005

Therapy/Procedure

8	Stem Cell Transplantation 01/2021 - 01/2017
7	Therapeutics 03/2024 - 04/2019
7	Hematopoietic Stem Cell Transplantation 01/2023 - 09/2014
3	Transplantation 01/2017 - 09/2014
2	Secondary Prevention 12/2019 - 12/2018
1	Artificial Respiration (Mechanical Ventilation) 03/2024
1	Cell Transplantation 01/2023
1	Catheters 09/2022
1	Central Venous Catheters 12/2021
1	Organ Transplantation 01/2021
1	Immunotherapy 12/2019
1	Drug Therapy (Chemotherapy) 10/2017